Deirdre A. Lane

Research interests

Publications

• 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation

  EP Europace · 2021 · https://doi.org/10.1093/europace/euab065

• Corrigendum to: 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC

  European Heart Journal · 2021 · https://doi.org/10.1093/eurheartj/ehab648

• Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

  Journal of the American College of Cardiology · 2020 · 10.1016/j.jacc.2020.01.052

• Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis

  PLoS Medicine · 2020 · 10.1371/journal.pmed.1003321

• Mobile Health Technology to Improve Care for Patients With Atrial Fibrillation

  Journal of the American College of Cardiology · 2020 · 10.1016/j.jacc.2020.01.052

• Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation

  Journal of the American College of Cardiology · 2019 · 10.1016/j.jacc.2019.08.019

• The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

  European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy136

• Antithrombotic Therapy for Atrial Fibrillation

  CHEST Journal · 2018 · 10.1016/j.chest.2018.07.040

• Stroke Prevention in Atrial Fibrillation

  JAMA · 2015 · 10.1001/jama.2015.4369

• Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data

  BMJ · 2015 · 10.1136/bmj.h4451

• Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation

  JAMA · 2015 · 10.1001/jama.2015.10725

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)

  European Heart Journal · 2014 · 10.1093/eurheartj/ehu298

• Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Asso

  European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu298

• The Global Burden of Atrial Fibrillation and Stroke

  CHEST Journal · 2012 · 10.1378/chest.11-2888

• Use of the CHA 2 DS 2 -VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation

  Circulation · 2012 · 10.1161/circulationaha.111.060061

• Performance of the HEMORR2HAGES, ATRIA, and HAS-BLED Bleeding Risk–Prediction Scores in Patients With Atrial Fibrillation Undergoing Anticoagulation

  Journal of the American College of Cardiology · 2012 · 10.1016/j.jacc.2012.06.019

• Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

  New England Journal of Medicine · 2012 · https://doi.org/10.1056/nejmoa1105594

• Antithrombotic Therapy for Atrial Fibrillation

  CHEST Journal · 2012 · 10.1378/chest.11-2304

• Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study

  Thrombosis and Haemostasis · 2011 · 10.1160/th11-05-0364

• Atrial fibrillation

  The Lancet · 2011 · 10.1016/s0140-6736(11)61514-6

• Comparative Validation of a Novel Risk Score for Predicting Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

  Journal of the American College of Cardiology · 2010 · 10.1016/j.jacc.2010.09.024

• Identifying Patients at High Risk for Stroke Despite Anticoagulation

  Stroke · 2010 · 10.1161/strokeaha.110.590257

• A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

  CHEST Journal · 2010 · 10.1378/chest.10-0134

• Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

  CHEST Journal · 2009 · 10.1378/chest.09-1584

• Quality of Life in Patients with Atrial Fibrillation: A Systematic Review

  The American Journal of Medicine · 2006 · 10.1016/j.amjmed.2005.10.057

• Mortality and Quality of Life 12 Months After Myocardial Infarction: Effects of Depression and Anxiety

  Psychosomatic Medicine · 2001 · 10.1097/00006842-200103000-00005

Current projects

No projects listed.